BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED

BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India) holds 162 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 40 active ingredients, holds 5 active Type IV (excipient) Drug Master Files and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/biophore-india-pharmaceuticals-private-limited

Overview

BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering VILOXAZINE HYDROCHLORIDE.

Core services & business areas

API ManufacturingPharmaceutical Manufacturing

Active ingredients with DMF or CEP filings

Substances for which BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED holds 162 active (162 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • SPARSENTANActive2026-08-31
  • RIBOCICLIBActive2026-07-31
  • ABEMACICLIBActive2026-06-30
  • TROFINETIDE (6105)Active2026-06-30
  • ELACESTRANT DIHYDROCHLORIDEActive2026-06-30
  • ELACESTRANT DIHYDROCHLORIDE PREMIX-IActive2026-05-30
  • OSILODROSTAT PHOSPHATEActive2026-03-31
  • OLAPARIB PREMIXActive2026-03-01
  • TROFINETIDEActive2026-03-01
  • LETERMOVIRActive2025-12-31
  • LOTILANERActive2025-12-31
  • NIRAPARIB TOSYLATEActive2025-12-31
  • MITAPIVAT SULFATEActive2025-10-31
  • MAVACAMTENActive2025-10-31
  • RESMETIROMActive2025-09-30
  • ATALURENActive2025-09-30
  • RIOCIGUATActive2025-07-31
  • RUCAPARIB CAMSYLATEActive2025-07-31
  • GADOXETATE DISODIUMActive2025-07-31
  • EDOXABAN TOSYLATEActive2025-07-01
  • MARALIXIBAT CHLORIDEActive2025-04-30
  • CARIPRAZINE HYDROCHLORIDE (6076)Active2025-04-24
  • ASCIMINIB HYDROCHLORIDE PREMIX-IActive2025-02-28
  • ASCIMINIB HYDROCHLORIDE PREMIXActive2024-12-31
  • RUXOLITINIB PHOSPHATEActive2024-12-31
  • NAPHAZOLINE NITRATEActive2024-12-31
  • AVATROMBOPAG MALEATEActive2024-12-28
  • SUVOREXANT PREMIXActive2024-12-20
  • TOLVAPTAN AMORPHOUSActive2024-10-10
  • FOSAPREPITANT DIMEGLUMINEActive2024-10-03
  • OLAPARIBActive2024-09-28
  • TOLVAPTAN CRYSTALLINEActive2024-09-19
  • SUVOREXANTActive2024-08-02
  • CALCIUM GLUCONATE MONOHYDRATEActive2024-04-30
  • RISDIPLAMActive2024-03-08
  • VILOXAZINE HYDROCHLORIDEActive2023-12-30
  • FLUORESCEIN SODIUMActive2023-12-30
  • BILASTINEActive2023-12-29
  • BEMPEDOIC ACIDActive2023-12-28
  • ISAVUCONAZONIUM SULFATEActive2023-09-22
  • CENOBAMATEActive2023-09-21
  • IRON SUCROSE (LIQUID)Active2023-07-31
  • INDAPAMIDEActive2023-07-31
  • GADOPENTETATE DIMEGLUMINEActive2023-07-17
  • TRIENTINE TETRAHYDROCHLORIDEActive2023-05-31
  • ELTROMBOPAG OLAMINEActive2023-03-31
  • SODIUM PHOSPHATE DIBASIC HEPTAHYDRATEActive2023-02-09
  • PITOLISANT HYDROCHLORIDE SOLID DISPERSIONActive2022-12-31
  • POTASSIUM PHOSPHATE DIBASICActive2022-12-29
  • SODIUM PHOSPHATE MONOBASICActive2022-12-27

Showing the 50 most relevant of 162 Drug Master Files (active first). The full list is in the FDA DMF list.

Excipient Drug Master Files

BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED holds 5 active (5 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.